Using chatgpt+aistudio as a daily driver. Decided to give @claudeai a try with $20 plan an opus 4.7. Here are quotes from a single conversation. How do people find this usable?
English
TheFullStackSnack
886 posts
TheFullStackSnack
@f_stack_snack
20+ years in programming for fun and profit | Improving tech one snack at a time 🍪💻 | working on local-first log querying tool 📊
Katılım Ekim 2024
66 Takip Edilen30 Takipçiler
I feel they need checkboxes there for more complete feedback
English
@claudeai is there a way to have yolo mode for dispatch? I have it running on a dedicated VM, that can be recreated in minutes with its own accounts. I want it to be helpful and autonomous when I send tasks from phone, but I have to stare at it and click allow every 15 seconds.
English
It only took 9 years for JetBrains to get to my issue… by a bot. What a time to be alive =)
English
@OpenAI Can we please don't degrade codex 5.3 xhigh on such occasions? At least for pro subscribers. I had to rewrite pretty much everything today.
English
@GeminiApp Any chance of 3 flash lite api being not more expensive than 2.5 flash lite? Price creep limits usage of new models with tasks that don't need very smart model, but need a cheap model
English
Gemini 3 Flash is here ⚡️
Get the free, fast, unlimited version of Gemini with our biggest upgrade yet.
See what’s new and how we’re using Gemini 3 Flash to tackle everyday tasks and get answers fast. (thread)
English
@Sauers_ Selfhosted runners on a 100 eur/mo hetzner instance give us way better experience
English
Gemini 3 Pro seems very smart so far but attention to details is a disaster.
English
I didn't update to MacOS 26 until 26.1. Upgraded today to find out that language switcher is still buggy. High quality software my ass...
English
@gdb Maybe the frontend team can use it to find out how to not annoy users by switching from pro model to auto after each message.
English
Taste of what LLM-driven scientific discovery will be like: with 12 minutes of thinking, GPT-5 Pro suggested repurposing a known drug to treat an untreatable food allergy. Same exact result was found by an (at the time unpublished) peer-reviewed study. And models still improving.
Derya Unutmaz, MD@DeryaTR_
Here is the story of a remarkable, independent treatment suggestion by GPT-5 Pro: repurposing a known drug for a patient with food protein–induced enterocolitis syndrome (FPIES). First, how we came to test this. My close friend, physician-scientist Dr. Oral Alpan, treated the patient described in the published report (link in the thread) for refractory allergic skin disease with the biologic dupilumab, which is approved for that indication. The patient also had FPIES, a food allergy that in his case was triggered by wheat and caused hours of cramping and watery, sometimes bloody, diarrhea. There is no approved treatment for FPIES; patients are advised to avoid trigger foods and prepare for emergencies if accidental exposure occurs. For twenty years, even a small amount of wheat set off the same cascade a few hours later, followed by days of recovery. After starting dupilumab for his skin condition, the patient traveled to France and accidentally ate a baguette. To his surprise, nothing happened! It was his first uneventful wheat exposure in two decades! On return, Dr. Alpan hypothesized that dupilumab might be responsible and supervised an oral food challenge approaching 50 grams of wheat protein. Again, no reaction! When an insurance interruption forced a pause in medication, the old symptoms returned; restarting it restored tolerance. In the peer-reviewed paper published today, Dr. Alpan and his team describe seven additional patients, ages 2 to 58, who responded to dupilumab for their FPIES condition. While this is not definitive proof and represents an observational case series, the findings suggest that dupilumab could be a potential treatment for FPIES. Dr. Alpan intends to contact Regeneron, the manufacturer, to pursue clinical studies hopefully toward FDA approval for this disease. About two months ago, as he had just submitted the paper on this case, Dr. Alpan told me this story. Until today’s publication there were no reports in the literature of dupilumab potentially treating FPIES. Around that time GPT-5 Pro had just been released, and I thought this would be a perfect case to test whether AI could infer a treatment from the clinical case alone. I remember anxiously watching it think for about 12 minutes. When the output appeared, I almost fell out of my chair! Its top recommendation read: “ dupilumab (IL-4Rα blocker).” (see attached screenshot). Just like my friend had done, it was leveraging the skin condition to treat FPIES. A key insight could be that GPT-5 Pro had recognized this drug is not only effective for the skin condition but also has a “broader epithelial effect,” while this has not been proven in FPIES patients, I think it is a plausible mechanism in this disease. It also listed other options that were mostly symptomatic and flagged one with an unfavorable side-effect profile. There were several other suggestions, though those are most obvious ones and also suggested by other models too. No other model I tried identified dupilumab as a first choice; though GPT-5 Thinking suggested it as a second or third options. Many other treatments for currently untreatable conditions may already exist and can be uncovered by using GPT-5 Pro and other advanced AI models to repurpose drugs (among 20,000 FDA approved drugs!). Of course these will still need to be clinically tested but this is how AI can help catalyze a healthcare revolution! I am very excited about what comes next and future AI models will be even more powerful to make such discoveries! Important safety and regulatory information: Dupilumab is not approved by the U.S. FDA for the treatment of FPIES. In this study, dupilumab was used on-label to treat each participant’s comorbid, FDA-approved allergic indication; the favorable FPIES observations occurred in that clinical context and should be considered off-label with respect to FPIES. Patients should not initiate or change therapy without consulting their physicians. This press release is for informational purposes only and is not medical advice. Also, as evidence that this was done before today’s publication, I sent a GPT-5 Pro link to friends at @OpenAI about two weeks ago to give them a heads-up, but I waited until the paper went online today to reveal this story.
English
@OpenAI Can you please stop switching from pro to auto after each message? It's really annoying, I expect some respect to my choice of the model for $200.
English
@YouTube Even Gemini knows that it is a very common and frustrating experience. Can you stop pushing "1 language is enough for everyone" paradigm?
English
Every san non-appstore app on mac: I'm running, let's use this time to download updates
MS Office on mac: it's my laptop now, go to setting and enable updater so I can run whenever I want, not whenever you want.
English
For example, I see a lazy rage baiting, but account seems kinda relevant to my interests at first glance. Now I have to make a decision right there whether to mute. I don't want to spend time analyzing post history, so the decision is semi-random. I'd rather give mute-strikes, and mute on 3.
English
If an account is found to use AI to write automated replies, they should be:
English
@DanielW_Kiwi @nikitabier I also want three strikes feature for muting accounts.
English
diskonaut is no longer in nixos packages. Is there a good alternative (speed + tui)?
English
English
